PeptidePedia The community reference

Information for Dual incretin agonist

Page information·measured at build time

Technical and provenance information about Dual incretin agonist. All figures on this page are measured from the emitted page rather than declared.

Basic information

Display titleDual incretin agonist
Default sort keyDual incretin agonist
NamespaceArticle (main)
Page kindConcept
Page length (source, bytes)5,851
Rendered word count732
Internal wiki links on the page23
Defined citations4
Top-level sections3
Subsections0
Tables0
Figures0
InfoboxYes — concept
Maintenance bannersNone
Indexing by robotsAllowed

Edit history

Page creatorMazdutideMads
Date of page creation22 July 2024
Latest editorHalfLifeHavel
Date of latest edit17 July 2026
Total number of edits37
Total number of distinct authors30
Minor edits15
Automated (bot) edits5
Recent number of edits (last 90 days)3
Talk page posts7

Principal authors

EditorEditsShareDeclared focus
BacWaterBarnaby38.1%dosing, titration and injection practice
CategoryBot38.1%categorisation and navigation
MazdutideMads25.4%GLP-1 receptor agonists and related compounds
MolarMassMaeve25.4%GLP-1 receptor agonists and related compounds
CuriousCallum25.4%GLP-1 receptor agonists and related compounds
OralSemaOswin12.7%GLP-1 receptor agonists and related compounds
TirzTaxonomist12.7%GLP-1 receptor agonists and related compounds
INN_Ingrid12.7%GLP-1 receptor agonists and related compounds
StubSorterBot12.7%categorisation and navigation
ReportReaderRilla12.7%third-party testing and certificates of analysis
API_Aurora12.7%compounding law and drug regulation
ParentCatPansy12.7%categorisation and navigation

Category membership